Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
09.12. | Rockland Trust To Acquire Enterprise Bank In $562 Mln Cash And Stock Deal | ||
09.12. | Virco Mfg. Q3 Net Income Declines | ||
09.12. | Carisma Therapeutics Announces Strategic Reprioritization Of Pipeline; To Cut Workforce By 34% | ||
09.12. | Achieve Life Sciences Appoints Mark Oki As New CFO | ||
09.12. | MeiraGTx Says FDA Grants RMAT Designation For AAV2-hAQP1 To Treat Radiation-Induced Xerostomia | ||
09.12. | Crinetics Pharmaceuticals: FDA To Review NDA For Paltusotine | ||
09.12. | Rent The Runway, Inc. Q3 Loss Declines | ||
09.12. | Relmada To Discontinue REL-1017 Reliance II And Relight Phase 3 Trials; Mulls Sale | ||
09.12. | Enanta Reports Positive Phase 2 Data For Zelicapavir In Paediatric RSV Study; Stock Up | ||
09.12. | Riot Platforms To Privately Place $500 Mln Of Convertible Sr. Notes; Stock Down 6% In Pre-market | ||
09.12. | Coherent To Expand 150 Mm Indium Phosphide Manufacturing Line | ||
09.12. | VersaBank Q4 Income Drops | ||
09.12. | Olema: FDA Clears Investigational New Drug Application For OP-3136; Trial To Initiate In Early 2025 | ||
09.12. | VirnetX Holding Names John Anthony Jamison CTO, Succeeding Victor Larson | ||
09.12. | Dow To Sell 40% Equity Stake In Select U.S. Gulf Coast Infrastructure Assets | ||
09.12. | Mullen Group Board Approves 2025 Plan | ||
09.12. | Eyenovia Prices $1.9 Mln Registered Direct Offering | ||
09.12. | CompuGroup Enters Strategic Partnership With CVC Capital Partners; CVC To Launch Public Tender Offer | ||
09.12. | Reckitt Benckiser To Commence Third Tranche Of Share Buyback Program | ||
09.12. | Skanska Signs Addl. SEK 1.2 Bln Contract For Part 2 Of NKT's Cable Factory In Sweden | ||
09.12. | CompuGroup Medical In Advanced Talks With CVC Capital For Investment Agreement | ||
08.12. | Genmab: Epcoritamab Combo Shows High Response Rates In 1b/2 Trial For R/R Follicular Lymphoma | ||
06.12. | Canadian Tire To Fully Retain Ownership Of Canadian Tire Financial Services | ||
06.12. | Landsea Homes Prices Secondary Offering Of 6.09 Mln Shares At $10.25/ Shr; Stock Down In Pre-market | ||
06.12. | U.K. CMA To Launch Formal Investigation Into Outbrain-Teads Deal |